Table 1.
Participant Characteristics, n = 358
| % (n) | M (SD) | Range | |
|---|---|---|---|
| Sociodemographics | |||
| Gender identity | |||
| Man | 89.1 (319) | ||
| Woman | 7.3 (26) | ||
| Transgender man | 0.6 (2) | ||
| Transgender woman | 2.2 (8) | ||
| Other | 0.9 (3) | ||
| Race/ethnicity | |||
| White | 2.2 (8) | ||
| African American or black | 86.6 (310) | ||
| Hispanic or Latino(a) | 9.2 (33) | ||
| Asian or Pacific Islander | 2.0 (7) | ||
| Years living with HIV | 6.60 (5.33) | 0–32 | |
| Substance use | |||
| # Substances used | 1.24 (1.13) | 0–6 | |
| Cannabis | 57.9 (208) | ||
| Alcohol | 24.2 (87) | ||
| Cocaine | 11.4 (41) | ||
| Methamphetamine | 9.7 (35) | ||
| Amphetamine | 8.1 (29) | ||
| Benzodiazepine | 4.2 (15) | ||
| Ecstasy (MDMA) | 3.1 (11) | ||
| Opioids | 1.9 (7) | ||
| Oxycodone | 1.4 (5) | ||
| Phencyclidine (PCP) | 0.6 (2) | ||
| Methadone | 0.6 (2) | ||
| Propoxyphene | 0.0 (0) | ||
| Barbiturates | 0.0 (0) | ||
| # Substances used at moderate or high risk | 2.01 (1.60) | 0–8 | |
| Cannabis | 57.9 (208) | ||
| Tobacco | 54.0 (194) | ||
| Alcohol | 33.4 (120) | ||
| Cocaine | 16.2 (58) | ||
| Inhalants | 13.1 (47) | ||
| Methamphetamine | 8.9 (32) | ||
| Amphetamine | 7.5 (27) | ||
| Sedatives | 2.8 (10) | ||
| Erectile dysfunction medication | 2.8 (10) | ||
| Other | 1.7 (6) | ||
| Hallucinogens | 1.1 (4) | ||
| Opioids | 0.9 (3) | ||
| # Times substances were used before sex in a month | 1.57 (2.95) | 0–20 | |
| Stigma | |||
| Internalized | 2.74 (1.58) | 1–6 | |
| Enacted | 0.45 (0.51) | 0–2.83 | |
| Depressive symptoms | 23.29 (8.98) | 0–46 | |
SD, standard deviation.